Access & Value · incretin drugs in Medicaid

When state Medicaid programs covered Wegovy and Zepbound, prescriptions rose by an estimated 12.2 per 1,000 enrollees per quarter

Public aggregate data, a tested warehouse and scenario analysis: what coverage was associated with, who is eligible, who prescribes, and what it could cost a program of 1 million enrollees.

Erick Kiprotich Yegon · Epidemiologist and data scientist · LinkedIn · keyegon@gmail.com

12.2estimated additional prescriptions per 1,000 enrollees per quarter95% CI 8.4 to 16.0; 10 covering vs 34 never-covering jurisdictions
128.8 millionU.S. adults meet the FDA label criteria (lower bound)95% CI 117.2 to 140.3 million; NHANES 2021-2023
$161.3 millionfive-year net cost, 1 million enrollees (central case)$2.69 per enrollee per month; scenario range $55.6 to $369.4 million; rebate assumed
Event-study plot of the estimated effect of coverage on Wegovy and Zepbound prescriptions per 1,000 enrollees by quarter since coverage began. Pre-coverage estimates are near zero; the effect is 1.3 at the start, 11.7 after four quarters and 17.2 after eight, with pointwise 95 percent bands widening later; event times 11 and 12 have fewer than three states and are grayed.
Estimated coverage effect by quarter since coverage began. Source: CMS State Drug Utilization Data and Medicaid enrollment. Part of the growth is national market growth.

What I did

  1. Public data
  2. PostgreSQL
  3. dbt: 54 models, 126 tests
  4. R analysis
  5. Quarto and Shiny

Sources: Medicaid State Drug Utilization Data and enrollment, Medicare Part D, NHANES, MEPS, Open Payments.

Methods shown

Causal inference (staggered difference-in-differences) · survey epidemiology · budget impact modeling with probabilistic sensitivity analysis · claims-derived data engineering (NDC, ICD-10, dbt) · market access insight.

What this shows

Data and notebooks

Budget model

The interactive budget model is a decision tool built around this project: set the plan size, uptake, prior authorization and price, then see the five-year net cost, its sensitivity drivers and a probabilistic range. Its defaults equal the numbers on this page. The scenarios are also in a PDF. The design pack for primary research is here.

Two projects, one portfolio